6-[3-[(4-fluorophenyl)methyl]-3-(hydroxymethyl)-1-piperidyl]pyrazine-2-carboxamide

ID: ALA4638490

Cas Number: 1332175-56-0

PubChem CID: 56739767

Max Phase: Preclinical

Molecular Formula: C18H21FN4O2

Molecular Weight: 344.39

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NC(=O)c1cncc(N2CCCC(CO)(Cc3ccc(F)cc3)C2)n1

Standard InChI:  InChI=1S/C18H21FN4O2/c19-14-4-2-13(3-5-14)8-18(12-24)6-1-7-23(11-18)16-10-21-9-15(22-16)17(20)25/h2-5,9-10,24H,1,6-8,11-12H2,(H2,20,25)

Standard InChI Key:  MCTLSQYQBQKNRU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   12.6542  -12.3518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3619  -11.9402    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0738  -12.3518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0738  -13.1668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3619  -13.5784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6542  -13.1668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9448  -13.5793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2374  -13.1679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5256  -13.5791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8218  -13.1685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8218  -12.3494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5272  -11.9431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2374  -12.3483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1143  -11.9421    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.6542  -13.9856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3616  -14.3970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3619  -11.1215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6546  -10.7139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6557   -9.8987    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3634   -9.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0710   -9.8936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0778  -10.7117    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7785   -9.4822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7785   -8.6635    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4859   -9.8936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  1  6  1  0
  6  7  1  0
  7  8  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
  8 13  1  0
 11 14  1  0
  6 15  1  0
 15 16  1  0
 17  2  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
 21 23  1  0
 23 24  2  0
 23 25  1  0
M  END

Associated Targets(Human)

TARDBP Tchem TAR DNA-binding protein 43 (40113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 344.39Molecular Weight (Monoisotopic): 344.1649AlogP: 1.54#Rotatable Bonds: 5
Polar Surface Area: 92.34Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.19CX Basic pKa: 0.33CX LogP: 1.51CX LogD: 1.51
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.86Np Likeness Score: -0.98

References

1. Brown DG, Shorter J, Wobst HJ..  (2020)  Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia.,  30  (4): [PMID:31926785] [10.1016/j.bmcl.2019.126942]

Source